Zhikun Liu

2.3k citations
115 papers · 1.5k indexed · h-index 23
Topics
Esophageal Cancer Research and Treatment (15 papers)Lung Cancer Diagnosis and Treatment (15 papers)Hepatocellular Carcinoma Treatment and Prognosis (13 papers)

In The Last Decade

Zhikun Liu

107 papers receiving 1.5k citations

Peers

Zhikun Liu
Comparison fields: 5 of 110
  • Molecular Biology 653
  • Oncology 411
  • Cancer Research 394
  • Pulmonary and Respiratory Medicine 259
  • Surgery 241
Replace Yifeng He with:
Yifeng He China
Sunbin Ling China
Sven A. Lang Germany
Peihua Luo China
Christoph Kornauth Austria
Keqiang Zhang China
Jindao Wu China
Mingxin Che United States
Yoshitaka Miyakawa Japan
Chiara Paglino Italy
Zhikun Liu relative to Yifeng He China Yifeng He's profile →
Citations per field
00.5×
Yifeng He · 1×
Citations per year

Countries citing papers authored by Zhikun Liu

Since Specialization
Citations

This map shows the geographic impact of Zhikun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhikun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhikun Liu more than expected).

Fields of papers citing papers by Zhikun Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhikun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhikun Liu. The network helps show where Zhikun Liu may publish in the future.

Co-authorship network of co-authors of Zhikun Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhikun Liu. A scholar is included among the top collaborators of Zhikun Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhikun Liu. Zhikun Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 2
5 1
6 9
7 7
8 3
9 44
10 2
11 1
12 1
13 2
14 14
15 1
16 56
17 2
18 1
19
Comparison of Clinical Efficacy and Complications in Three Common Methods for the Treatment of Axillary Osmidrosis
1
20 1

About Zhikun Liu

Zhikun Liu is a scholar working on Hepatology, Oncology and Cancer Research, having authored 115 papers that have together received 1.5k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (15 papers), Lung Cancer Diagnosis and Treatment (15 papers) and Hepatocellular Carcinoma Treatment and Prognosis (13 papers). The work is most often cited by research in Cancer Research (394 citations), Hepatology (191 citations) and Oncology (411 citations). Zhikun Liu has collaborated with scholars based in China, Madagascar and United Kingdom. Frequent co-authors include Xiao Xu, Shusen Zheng, Haiyang Xie, Shaohua Gou, Heng‐Shan Wang, Xuyong Wei, Lin Zhou, Qi Ling, Yichao Wu and Shusen Zheng. Their work appears in journals such as Journal of Hazardous Materials, Scientific Reports and ACS Applied Materials & Interfaces.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026